New Ray Medicine International Holding Limited (HKG:6108)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2080
0.00 (0.00%)
Last updated: Apr 2, 2026, 10:05 AM HKT

Revenue by Segment

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Provision of Marketing and Promotion Services of Drugs
2.44M5.24M7.30M6.02M5.76M
Provision of Marketing and Promotion Services of Drugs Growth
-53.41%-28.28%21.36%4.48%27.41%
Distribution and Trading of Pharmaceutical Products
127.93M88.71M42.85M83.75M329.62M
Distribution and Trading of Pharmaceutical Products Growth
44.22%107.01%-48.84%-74.59%156.13%
Total
130.37M93.95M50.15M89.77M335.38M
Total Growth
38.78%87.31%-44.13%-73.23%151.76%

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
People's Republic of China (PRC)
130.37M93.95M50.15M89.77M335.38M
People's Republic of China (PRC) Growth
38.78%87.31%-44.13%-73.23%151.76%
Total
130.37M93.95M50.15M89.77M335.38M
Total Growth
38.78%87.31%-44.13%-73.23%151.76%
Source: S&P Global Market Intelligence.